ACM
IRON icon

Aster Capital Management’s Disc Medicine IRON Stock Holding History

Aster Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58K Buy
+52
New +$3.61K ﹤0.01% 739
2025
Q4 		– Sell
-576
Closed -$38.1K – 1257
2025
Q3 		$38.1K Buy
+576
New +$34.3K 0.02% 553
2025
Q2 		– Sell
-577
Closed -$32.4K – 1305
2025
Q1 		$32.4K Buy
577
+523
+969% +$29.1K 0.01% 908
2024
Q4 		$3.42K Buy
54
+48
+800% +$2.78K ﹤0.01% 910
2024
Q3 		$295 Buy
+6
New +$282 ﹤0.01% 1056

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aster Capital Management's IRON Position: Q1 2026 in Review

Aster Capital Management opened a new position in Disc Medicine (IRON) in Q1 2026: 52 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #739 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in IRON as recently as Q3 2025.

Aster Capital Management first reported a position in IRON in Q3 2024 and has held it in 5 quarters since. The position peaked at $38.1K in Q3 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Aster Capital Management held 52 shares of Disc Medicine worth $2.58K as of Q1 2026.
  • Disc Medicine was a new Aster Capital Management position in Q1 2026.
  • Disc Medicine made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #739 holding.
  • Aster Capital Management first reported a position in Disc Medicine in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Disc Medicine position peaked at $38.1K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.